U.S. Water Utilities Stock News

What triggered the latest focus on Tronox Holdings (TROX)? Tronox Holdings (TROX) just paired higher fourth quarter 2025 revenue guidance of US$730 million with plans to permanently close its TiO2 plant in Fuzhou, China, highlighting both growth expectations and a shift in its cost base. See our latest analysis for Tronox Holdings. The guidance upgrade and Fuzhou closure come after a sharp 102.05% 90 day share price return and 61.83% year to date gain, even though the 1 year total shareholder...

Xcel Energy (NasdaqGS:XEL) has entered new alliances with GE Vernova and NextEra Energy to expand renewable energy infrastructure and support growing power needs from data centers. The company is also advancing the proposed PowerOn Midwest transmission line to connect new energy sources to the grid and support regional reliability. These agreements include work on gas and wind turbines, grid modernization, AI applications, and added capacity for large data center customers. Xcel Energy,...

If you are looking at On Holding and wondering whether the current share price still represents good value, it helps to break the story into what the stock has done and how that lines up with what it might be worth. The share price closed at US$42.92, with returns of a 4.7% decline over 7 days, a 12.5% decline over 30 days, an 8.6% decline year to date, a 28.1% decline over 1 year and a 102.6% gain over 3 years. This can leave the stock feeling very different depending on your time...

In November 2025, Tutor Perini Corporation reported strong third-quarter and year-to-date results, prompting its Board to declare a quarterly cash dividend and authorize a US$200 million share repurchase program while raising 2025 earnings guidance. The combination of a new dividend, sizable buyback, and guidance increase against a record construction backlog signals management’s confidence in the company’s cash generation and project pipeline. Next, we will examine how the new US$200...

If you are wondering whether Corvus Pharmaceuticals at US$19.06 is still offering value after a strong run, the key question now is how that price stacks up against what the business might be worth. The stock has been very volatile recently, with a 30 day return of 185.3%, a 1 year return of 253.6%, and a 3 year return that is well over 7x, even though the last 7 days saw a 9.0% decline. That mix of sharp gains and a recent pullback often lines up with shifting expectations around the...

Century Aluminum and Emirates Global Aluminium plan to build a major new aluminum smelter in Oklahoma, described as the first large scale U.S. facility of its kind in nearly 50 years. The company has agreed to sell its Hawesville, Kentucky site for redevelopment into a large digital infrastructure and AI data campus. Together, these moves reshape how Century Aluminum uses key assets and expand its role in U.S. industrial supply chains. For investors watching NasdaqGS:CENX, these...

Yum China Holdings (NYSE:YUMC) reported strong Q4 and full-year 2025 results, with solid revenue and profit performance. The company announced a 21% increase in its cash dividend, signaling a higher level of cash being returned to shareholders. Yum China continued rapid expansion, adding over 1,700 net new stores in 2025 and outlining further growth plans with more emphasis on franchising. For investors tracking NYSE:YUMC, the news comes at a time when the share price is $55.67 and recent...

If you are wondering whether Match Group's current share price reflects its underlying value, you are not alone and this article will walk through what the numbers actually say. Match Group's share price closed at US$30.85, with returns of a 1% decline over the past week, a 5.3% decline over the past month and a 2.8% decline year to date, alongside a 6.6% decline over 1 year, a 29.5% decline over 3 years and an 81.3% decline over 5 years. These moves sit against a backdrop of ongoing...

In late 2025, Union Pacific announced a landmark agreement with Westinghouse Air Brake Technologies (Wabtec) worth US$1.20 billion to modernize its AC4400 locomotive fleet, extending asset life while improving efficiency, reliability and digital capabilities across more than 1,700 units with deliveries starting in 2027. This deal, described as the largest locomotive modernization investment in rail industry history, underscores how freight railroads are using technology upgrades rather than...

Dillard's (DDS) recently reported a Q3 update with revenue up 2.7% year over year and earnings above analyst expectations. Management also highlighted sales momentum that it expects to carry through the holiday season. See our latest analysis for Dillard's. Despite the latest share price of $635.51 and a 1 day share price return of 2.68% decline, Dillard's has a 1 year total shareholder return of 40.67% and a very large 5 year total shareholder return. This suggests long term holders have...

Event context and recent stock performance WeShop Holdings (WSHP) has recently been in focus after a sharp move in its share price, with the stock closing at $52.51 and recording a 1 day return of 0.11%. Over the past week, the stock shows a 19.22% decline, while the past month return stands at a 39.66% decline. This is prompting investors to reassess how this social e commerce platform’s fundamentals align with recent trading. See our latest analysis for WeShop Holdings. That sharp 39.66% 1...

In recent months, Navitas Semiconductor has been shifting away from its mobile and consumer operations toward higher-margin AI infrastructure and industrial electrification applications, even as this transition has weighed on near-term revenue. An important angle for investors is how Navitas’ partnerships, including with Nvidia and major EV and PC makers, could reshape its role across AI and data center supply chains. Next, we’ll examine how this renewed focus on AI infrastructure and...

Embecta's Q1 2026 Earnings Snapshot Embecta (EMBC) opened its fiscal 2026 with Q1 revenue of US$261.2 million, basic EPS of US$0.75 and net income of US$44.1 million, providing a clear view of how its core diabetes-care franchise is tracking. The company reported quarterly revenue of US$261.9 million in Q1 2025 compared with US$261.2 million in Q1 2026, while basic EPS moved from US$0.25 in Q4 2024 to US$0.75 in the latest quarter, giving investors a new perspective on earnings power as...

Why UFP Industries’ recent trends are back in focus UFP Industries (UFPI) is back under the microscope after ongoing declines in unit sales, earnings per share, and returns on capital over the past two years raised fresh questions about the durability of its profit drivers. See our latest analysis for UFP Industries. At a share price of $112.72, UFP Industries has seen strong recent momentum, with a 30 day share price return of 18.82% and a 90 day share price return of 22.52%. This comes even...

Vicor (NasdaqGS:VICR) reports a surge in high margin IP licensing and royalty revenue following favorable International Trade Commission (ITC) rulings. The ITC outcomes support Vicor's efforts to monetize its power conversion intellectual property across a broader set of industry partners. These developments point to a potential inflection in Vicor's business model, with licensing now playing a larger role alongside product sales. For you as an investor, the key point is that Vicor is known...

Recent performance snapshot Ducommun (DCO) has drawn fresh attention after recent share price moves, with the stock last closing at $119.25. That puts the company’s recent 1 year and multi year total returns firmly in focus for investors. See our latest analysis for Ducommun. Those recent gains fit into a stronger trend, with a 30 day share price return of 18.02% and a 1 year total shareholder return of 78.71% pointing to building momentum rather than a short lived bounce. If Ducommun’s move...

If you are wondering whether East West Bancorp is offering fair value at its current share price, this breakdown will help you connect the recent share performance with what the fundamentals suggest. The stock last closed at US$118.46, with returns of 3.5% over the past 7 days, 0.7% over 30 days, 3.0% year to date, 19.1% over 1 year, 65.5% over 3 years, and 103.0% over 5 years. This naturally raises questions about what is already reflected in the price. Recent news coverage around US...

Insulet has launched its Omnipod 5 Automated Insulin Delivery System in selected Middle Eastern markets. The company also introduced Omnipod Discover, a new data and analytics platform for diabetes management. Both products expand Insulet's global footprint and broaden its connected product ecosystem around Omnipod. Insulet, traded as NasdaqGS:PODD, is adding fresh product news at a time when its share price is $243.15. The stock has seen a 17.4% decline over the past 30 days and a 15.5%...

If you are wondering whether Summit Therapeutics at around US$13.85 is pricing in too much hope or not enough, you are in the right place for a clear look at what the market might be implying about its value. The share price has seen sharp swings, with a 10.1% decline over the past week, a 25.8% decline over the past month, a 20.9% decline year to date, yet a very large gain over three years and an 87.9% gain over five years. These moves have come as Summit Therapeutics continues to attract...

Investors wondering whether Nextpower is still fairly priced after a strong run, or if the share price has moved ahead of the underlying value, will find that this article focuses squarely on what the current valuation might be indicating. The stock recently closed at US$114.44, with a 30 day return of 25.1% and a 1 year return of 140.4%. Over the last 7 days, however, the share price has pulled back 5.5%, which may reflect some reassessment of risk or profit taking after a 23.3% year to...

Innodata (NasdaqGM:INOD) has entered into a partnership with Palantir to provide specialized data engineering and annotation for advanced AI projects. The collaboration focuses on complex, real world use cases, including video annotation and multimodal generative AI workflows for performance analytics in ride event analysis. The agreement positions Innodata as a key data partner for high stakes AI deployments where quality, security and domain specific workflows are central...

If you are wondering whether Lear’s current share price really reflects its underlying value, you are not alone. This article is designed to help you frame that question clearly. Lear’s share price recently closed at US$136.05, with returns of 12.8% over the last 7 days, 10.2% over 30 days, 14.7% year to date, 48.3% over 1 year, 6.6% over 3 years, and a 5.1% decline over 5 years. Recent attention on Lear has been shaped by company updates and sector headlines that have put auto related...

If you are wondering whether MetLife's current share price reflects its true worth, you are not alone. That is exactly what this valuation focused review aims to unpack. MetLife recently closed at US$75.32, with returns of 3.7% decline over 7 days, 7.2% decline over 30 days, 6.2% decline year to date and 7.3% decline over 1 year, compared with longer term returns of 16.8% over 3 years and 58.5% over 5 years. Recent attention around MetLife has centered on its position as a large, established...

Corteva (NYSE:CTVA) has reached a comprehensive settlement with Bayer that resolves all "freedom to operate" litigation between the two companies. The agreement is expected to support Corteva's corn licensing activities and open a path into the cotton licensing market. Separately, Corteva is moving ahead with a planned separation of its seed operations into a standalone company. The spin off may include relocating the new seed company headquarters to Iowa, with implications for regional...